Incidence, clinical risk factors, and biomarkers of SOS/VOD following allogeneic HSCT in adults. A real-life study by the Spanish group of HSCT and cell therapy (GETH-TC).
Ariadna Pérez‐Martínez, Mónica Cabrero, Juan Montoro, Miriam Sánchez‐Escamilla et autres
es, ps (code pays fourni par la source)